6550--FY27 Qiagen Reagents and Controls
Veterans Affairs · 248-NETWORK CONTRACT OFFICE 8 (36C248)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24826Q1168 in this department, oldest first.
- Aug 24, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
The Department of Veterans Affairs, NCO 8, intends to award a sole source, firm fixed price contract under FAR 6.302 1, Only One Responsible Source, to QIAGEN LLC, Germantown, MD, for QuantiFERON (QFT) TB Gold Plus II reagents and controls used for Interferon Gamma Release Assay (IGRA) testing at the James A. Haley Veterans Hospital (JAHVH). The contract will be established as a five year BPA (Base Year + 4 Option Years). The applicable NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), PSC 6640. This notice is not a solicitation. No solicitation will be issued. The Governm… (show all)
ent intends to solicit and negotiate with only one source, as the required QuantiFERON TB Gold Plus II reagents are exclusively manufactured by QIAGEN and are uniquely compatible with the DiaSorin LIAISON XL analyzer currently in use at JAHVH. Interested parties may submit capability statements demonstrating the ability to provide fully compatible supplies no later than 10:00 AM ET, August 28, 2026, to Quentin.Ford@va.gov. Proprietary information must be clearly marked. The Government will evaluate responses solely to determine whether competition is viable; however, a decision not to compete remains at the Government s discretion. Point of Contact: Quentin Ford, Contracting Officer, NCO 8 Statement of Need QIAGEN QuantiFERON TB Gold Plus II Reagents and Controls Overview: The Pathology and Laboratory Medicine Service at JAHVH requires FDA approved, DiaSorin compatible reagents and controls for QuantiFERON TB Gold Plus II testing to support in house IGRA testing for Veterans and employee TB screening. Requirement Summary: Provide QIAGEN QuantiFERON TB Gold Plus II reagents and controls fully compatible with the DiaSorin LIAISON XL analyzer. Support continuous IGRA testing for clinical and occupational health needs. Furnish monthly deliveries of required reagents; shipping included. Supply products meeting CAP, JCAHO, and VA laboratory standards. No site preparation required equipment already installed. Routine daily maintenance and QC performed by VA staff. Equipment maintenance is covered under a separate DiaSorin service contract.
Who won similar work
14 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 334516.
| Winner | Awards | Value | Last |
|---|---|---|---|
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 3 | $4.4M | Apr 22, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 2 | $3.8M | May 27, 2026 |
| CEPHEID SUNNYVALE 94089 | 2 | $843K | Oct 5, 2026 |
| SEBIA, INC. | 1 | $3.6M | May 4, 2026 |
| ABBOTT LABORATORIES INC. · $ABT | 1 | $3.4M | Apr 27, 2026 |
| Fisher Scientific Company · $TMO | 1 | $2.7M | Mar 31, 2026 |
| BECKMAN COULTER, INC. | 1 | $1.4M | Mar 12, 2026 |
| HOLOGIC SALES AND SERVICE, LLC | 1 | $245K | May 4, 2026 |
| STRIPES GLOBAL, INC. | 1 | $148K | Mar 25, 2026 |
| FRANKLIN YOUNG INTERNATIONAL, INCORPORATED | 1 | $83K | Oct 1, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 5, 2026CEPHEID SUNNYVALE 94089$561K6640--FY27 Cepheid - Base Plus 4 Option Years (VA-27-00000309)
- May 27, 2026GOVERNMENT SCIENTIFIC SOURCE INC$3.2M6550--FY26: Leica Bond III Reagents
- May 4, 2026SEBIA, INC.$3.6M6640--VISN 8 Electrophoresis Testing
- May 4, 2026HOLOGIC SALES AND SERVICE, LLC$245K6632--Automated Cytology CPT
- Apr 27, 2026ABBOTT LABORATORIES INC.$3.4M6632--Chemistry CPRR with Automation
- Apr 22, 2026POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$205K6515--Automated iFOBT CPT- OY1
- Apr 16, 2026POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$3.5M6640--VISN 8 Mail FIT Kits
- Mar 31, 2026Fisher Scientific Company$2.7M6640--Allergy and Autoimmune Disease (TAM and BP)
- Mar 25, 2026STRIPES GLOBAL, INC.$148K6632--Automated Osmolality Testing
- Mar 12, 2026BECKMAN COULTER, INC.$1.4M6550--FY26: Automated Flow Cytometry CPRR
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (6 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $88K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 8 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 2 of the past winners are listed companies
- 0 insider buys and 9 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.